Review Article

[Retracted] Effects and Safety of Sacubitril/Valsartan for Patients with Myocardial Infarction: A Systematic Review and Meta-Analysis

Table 1

Baseline characteristics of included studies.

AuthorYearDiseaseNo. of exp.No. of con.Age of exp.No. of con.Sex of exp. (M/total)Sex of con. (M/total)Intervention (exp.)Intervention (con.)

Chi Chen2021Acute myocardial infarction423951.28 ± 6.2751.3 ± 6.2127/4224/39Sacubitril/valsartanBisoprolol

Kieran F. Docherty2021Myocardial infarction474661.8 ± 10.659.7 ± 10.142/4743/46Sacubitril/valsartanValsartan

Ahmed Rwzq, MD. PHD.2020ST-segment elevation myocardial infarction10010052 ± 9.257 ± 11.686/10088/100Sacubitril/valsartanRamipril

Haiyan Wang2020Acute anterior wall myocardial infarction686959.13 ± 7.1560.56 ± 7.6252/6854/69Sacubitril/valsartanEnalapril

Yi Zhang2020ST-elevation myocardial infarction797760.3 ± 11.760 ± 10.959/7955/77Sacubitril/valsartanACEI